Sansum Diabetes Research Institute

CLINICAL TRIALS

CURRENT ADULT STUDIES

Multi-center Trial in Adult and Pediatric Patients With Type 1 Diabetes Using Hybrid Closed Loop System at Home

Please contact Molly Piper for more information, mpiper@sansum.org or call 805-682-7640 ext. 214

The International Diabetes Closed Loop (iDCL) Trial: Clinical Acceptance of the Artificial Pancreas (DCLP3 Extension)

Please contact Molly Piper for more information, mpiper@sansum.org or call 805-682-7640 ext. 214

Comparison of Insulin Degludec with Insulin Glargine U100 for adults with type 1 diabetes traveling across multiple time zones. A pilot study.

Please contact Christian Farfan for more information, cfarfan@sansum.org or call 805-682-7640

Dexcom Continuous Monitoring and Control of Hypoglycemia (COACH)

Please contact Christian Farfan for more information, cfarfan@sansum.org or call 805-682-7640

FreeStyle Libre Flash Glucose Monitoring System Post Approval Study

Please contact Christian Farfan for more information, cfarfan@sansum.org or call 805-682-7640

Abbott Sensor Based Glucose Monitoring System Characterization Study using Capillary Glucose Reference.

Subjects must be: At least 18 years of age; require insulin therapy through an insulin pump and/or multiple daily injections (at least 3 injections daily), and be able to commit to 21 days participation.

Please contact Christian Farfan for more information, cfarfan@sansum.org or call 805-682-7640

YSI Feasibility Study of the Dexcom® Continuous Glucose Monitoring (CGM) System in Adults and Pediatrics with Diabetes Mellitus.

Must be: Ages 6 years or older, Diagnosed with Type 1 or Type 2 Diabetes Mellitus

Please contact Christian Farfan for more information, cfarfan@sansum.org or call 805-682-7640

CURRENT PEDIATRIC STUDIES

Multi-center Trial in Adult and Pediatric Patients With Type 1 Diabetes Using Hybrid Closed Loop System at Home

Please contact Molly Piper for more information, mpiper@sansum.org or call 805-682-7640 ext. 214

The International Diabetes Closed Loop (iDCL) Trial: Clinical Acceptance of the Artificial Pancreas (DCLP3 Extension

Please contact Molly Piper for more information, mpiper@sansum.org or call 805-682-7640 ext. 214

Freestyle Libre Flash Glucose Monitoring System Pediatric Accuracy Study

Please contact Christian Farfan for more information, cfarfan@sansum.org or call 805-682-7640

Freestyle Libre Flash Glucose Monitoring System Post Approval Study for Pediatric Patients

Please contact Christian Farfan for more information, cfarfan@sansum.org or call 805-682-7640

FreeStyle Libre Flash Glucose Monitoring System in Pediatric Populations

Please contact Christian Farfan for more information, cfarfan@sansum.org or call 805-682-7640

Dexcom Continuous Monitoring and Control of Hypoglycemia (COACH)

Please contact Christian Farfan for more information, cfarfan@sansum.org or call 805-682-7640

Effectiveness and Safety Study of the FreeStyle Libre Flash Glucose Monitoring System in Pediatric Populations.

Must be: 6-17 years of age and weigh at least 57.2 pounds.

Please contact Christian Farfan for more information, cfarfan@sansum.org or call 805-682-7640

CURRENT PREGNANCY STUDIES

Longitudinal Observation of Insulin Requirements and Sensor Use in Pregnancy (LOIS-P)

Evaluating the safety and accuracy of CGM in pregnancy. These research projects include an in-clinic portion and will have standard subject reimbursement. Principal Investigators: Kristin Castorino, DO and Jordan Pinsker, MD

Please contact Molly Piper for more information, mpiper@sansum.org or call 805-682-7640 ext. 214

CGM Accuracy in Pregnancy Research

Who: Pregnant women with any type of diabetes

When: Open Enrollment

Duration: Approximately 2 weeks

Please contact Kristen Nelson for more information, knelson@sansum.org or call 805-682-7640 ext. 252

GDM Prevention Study

We are a clinical site for CalPoly Stride Program’s GDM Prevention study. The gestational diabetes prevention program is studying whether weight loss before your next pregnancy can help prevent gestational diabetes from happening again. Principal Investigator: Suzanne Phelan, PhD

Who: Postpartum women with history of GDM who might have another baby

When: Open Enrollment

Duration: Approx 12 week intervention with follow-up if you become pregnant

Please contact Kristen Nelson for more information, knelson@sansum.org or call 805-682-7640 ext. 252